Long-term outcomes of Spetzler-Martin grade IV and V arteriovenous malformations: a single-center experience

Abstract

Intervention is reasonable for properly indicated SM grade IV-V AVMs because it provides satisfactory seizure control with decreased risks of severe disability and subsequent hemorrhage than conservative management. Clinical trial registration no.: NCT04572568 (ClinicalTrials.gov).